Oral contraceptive use and risk of melanoma in premenopausal women.

被引:0
|
作者
Feskanich, D [1 ]
Hunter, DJ [1 ]
Colditz, GA [1 ]
机构
[1] Harvard Univ, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
183
引用
收藏
页码:S46 / S46
页数:1
相关论文
共 50 条
  • [31] Hormonal contraceptive use after a first venous thrombotic event and the risk of recurrence in premenopausal women
    Verlaan, Judith P. L.
    Stegeman, Bernadine H.
    Timp, Jasmijn F.
    Scheres, Luuk J. J.
    Flinterman, Linda E.
    Helmerhorst, Frans M.
    Rosendaal, Frits R.
    Cannegieter, Suzanne C.
    Vlieg, Astrid van Hylckama
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (08) : 2195 - 2202
  • [32] Risk of Cancer with Combined Oral Contraceptive Use among Iranian Women
    Vaisy, Afasaneh
    Lotfinejad, Shirin
    Zhian, Faegh
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (14) : 5517 - 5522
  • [33] ORAL-CONTRACEPTIVE USE AND RISK OF CUTANEOUS MALIGNANT-MELANOMA IN A CASE-CONTROL STUDY OF FRENCH WOMEN
    LE, MG
    CABANES, PA
    DESVIGNES, V
    CHANTEAU, MF
    MLIKA, N
    AVRIL, MF
    CANCER CAUSES & CONTROL, 1992, 3 (03) : 199 - 205
  • [34] CUTANEOUS MELANOMA IN WOMEN .3. REPRODUCTIVE FACTORS AND ORAL-CONTRACEPTIVE USE
    HOLLY, EA
    CRESS, RD
    AHN, DK
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 141 (10) : 943 - 950
  • [35] Oral contraceptive use and risk of fractures
    Vestergaard, Peter
    Rejnmark, Lars
    Mosekilde, Leif
    CONTRACEPTION, 2006, 73 (06) : 571 - 576
  • [36] Oral contraceptive use and risk of endometriosis
    Parazzini, F
    Di Cintio, E
    Chatenoud, L
    Moroni, S
    Mezzanotte, C
    Crosignani, G
    Ardovino, I
    Struzziero, E
    Zanardi, E
    Pungetti, D
    Mais, V
    Ajossa, S
    Mignemi, G
    Di Leo, L
    Bianchi, A
    Campobaso, C
    Scarselli, G
    Bracco, G
    Capetta, P
    Bertulessi, C
    Moroni, S
    Mazza, P
    Vercellini, P
    Modena, AB
    Cirziz, E
    Casa, A
    Primicerio, M
    Massobrio, M
    Ansaldi, C
    Trossarelli, G
    Gervasi, MT
    Marsoni, V
    Guaschino, S
    Troiano, L
    Ricci, G
    Beretta, P
    Franchi, M
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1999, 106 (07): : 695 - 699
  • [37] PATTERNS OF ORAL CONTRACEPTIVE USE AND PLASMA INSULIN-LIKE GROWTH FACTOR-1 LEVELS IN PREMENOPAUSAL WOMEN: IMPLICATIONS FOR DISEASE RISK
    Blackmore, K. M.
    Wong, J.
    Knight, J. A.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2010, 171 : S38 - S38
  • [38] Oral Contraceptive Use and Assessment of Breast Cancer Risk among Premenopausal Women via Molecular Characteristics: Systematic Review with Meta-Analysis
    Baranska, Agnieszka
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (22)
  • [39] ORAL-CONTRACEPTIVE USE AND MALIGNANT-MELANOMA
    HENNEKENS, CH
    BAIN, C
    SPEIZER, FE
    ROSNER, B
    WILLETT, W
    BELANGER, C
    CLINICAL RESEARCH, 1982, 30 (02): : A237 - A237
  • [40] ORAL-CONTRACEPTIVE USE AND MALIGNANT-MELANOMA
    BAIN, C
    HENNEKENS, CH
    SPEIZER, FE
    ROSNER, B
    WILLETT, W
    BELANGER, C
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1982, 68 (04) : 537 - 539